Addus HomeCare (NASDAQ:ADUS) Announces Earnings Results

Addus HomeCare (NASDAQ:ADUS) issued its quarterly earnings results on Monday. The company reported $1.77 earnings per share for the quarter, topping the consensus estimate of $1.71 by $0.06, FiscalAI reports. The company had revenue of $372.08 million during the quarter. Addus HomeCare had a net margin of 6.36% and a return on equity of 9.53%.

Addus HomeCare Stock Performance

Shares of NASDAQ:ADUS traded up $2.15 on Monday, hitting $117.63. The company had a trading volume of 325,826 shares, compared to its average volume of 218,505. The stock has a market cap of $2.17 billion, a price-to-earnings ratio of 25.19, a P/E/G ratio of 1.39 and a beta of 0.91. The company has a current ratio of 1.66, a quick ratio of 1.66 and a debt-to-equity ratio of 0.14. The stock has a 50 day moving average price of $109.79 and a 200 day moving average price of $113.09. Addus HomeCare has a 1-year low of $88.96 and a 1-year high of $124.43.

Institutional Trading of Addus HomeCare

Institutional investors have recently added to or reduced their stakes in the company. Global Retirement Partners LLC boosted its holdings in Addus HomeCare by 395.7% in the 4th quarter. Global Retirement Partners LLC now owns 233 shares of the company’s stock valued at $25,000 after purchasing an additional 186 shares during the period. Larson Financial Group LLC increased its position in shares of Addus HomeCare by 133.3% in the third quarter. Larson Financial Group LLC now owns 238 shares of the company’s stock worth $28,000 after purchasing an additional 136 shares during the period. Acumen Wealth Advisors LLC bought a new stake in Addus HomeCare during the fourth quarter worth about $29,000. Arax Advisory Partners grew its stake in Addus HomeCare by 95.8% during the fourth quarter. Arax Advisory Partners now owns 280 shares of the company’s stock worth $30,000 after buying an additional 137 shares in the last quarter. Finally, Wexford Capital LP bought a new position in Addus HomeCare in the 3rd quarter valued at about $41,000. 95.35% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

Several brokerages have issued reports on ADUS. TD Cowen reiterated a “buy” rating on shares of Addus HomeCare in a research note on Wednesday, November 5th. Barclays raised their price objective on Addus HomeCare from $111.00 to $117.00 and gave the company an “underweight” rating in a report on Tuesday, November 4th. Wall Street Zen upgraded Addus HomeCare from a “buy” rating to a “strong-buy” rating in a report on Monday. BMO Capital Markets assumed coverage on Addus HomeCare in a research report on Thursday, November 13th. They set a “market perform” rating and a $120.00 price target for the company. Finally, Royal Bank Of Canada upped their price objective on Addus HomeCare from $134.00 to $139.00 and gave the stock an “outperform” rating in a research note on Friday, November 7th. One equities research analyst has rated the stock with a Strong Buy rating, six have given a Buy rating, two have given a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, Addus HomeCare has a consensus rating of “Moderate Buy” and a consensus price target of $135.44.

Addus HomeCare Company Profile

Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.

The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.